aucubin has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, D; Jiang, H; Lian, X; Ma, L; Ma, Q; Wang, N; Xue, H | 1 |
| Fang, XM; Gao, GZ; Jin, LJ; Lu, YN; Xu, YP; Xue, HY | 1 |
2 other study(ies) available for aucubin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Determination of aucubin by supramolecular solvent-based dispersive liquid-liquid microextraction and UPLC-MS/MS: Application to a pharmacokinetic study in rats with type 1 diabetes.
Topics: Animals; Area Under Curve; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Iridoid Glucosides; Liquid Phase Microextraction; Male; Rats; Rats, Sprague-Dawley; Solvents; Tandem Mass Spectrometry | 2020 |
Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats.
Topics: Animals; Blood Glucose; Body Weight; Brain Diseases, Metabolic; CA1 Region, Hippocampal; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Iridoid Glucosides; Male; Neuroprotective Agents; Pyramidal Cells; Rats; Rats, Wistar | 2012 |